marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-05-2024
Vertex Pharmaceuticals Incorporated DSO Ratio 2011-2024 | VRTX
Annual DSO Ratio Vertex Pharmaceuticals Incorporated
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.6 | 52.7 | 48.7 | 44.7 | 55.5 | 57.1 | 56.4 | 43.8 | 66.9 | 56.6 | 25.8 | 34.2 | 47.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 66.9 | 25.8 | 49.6 |
Quarterly DSO Ratio Vertex Pharmaceuticals Incorporated
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.1 | 59.5 | 56.9 | - | 56.9 | 56.8 | 57.4 | - | 27.1 | 26.9 | 52.9 | - | 46.7 | 48.5 | 49.3 | 49.6 | 52.5 | 53 | 45.7 | 40.9 | 60.9 | 61.4 | 55.5 | 43 | 47.6 | 49.7 | 49.2 | 39.4 | 44.4 | 47.2 | 30.8 | 39.9 | 44.3 | 42.5 | 43 | 38 | 51.8 | 97.6 | 83.5 | 48 | 38.7 | 50.1 | 62.2 | 22.2 | 35.2 | 25.1 | 31.8 | 39.1 | 38.9 | 31.2 | 33.9 | 29.7 | 25.4 | 146 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 146 | 22.2 | 48.3 |